Label reference · Endocrine & metabolic
Fiasp (Insulin Aspart Injection) Injection, Solution Fiasp (Insulin Aspart) Injection, Solution — label reference
DailyMed · Retrieved 2026-10-13
Fiasp is listed in DailyMed as injection, solution. Active ingredient: insulin aspart. This reference records product facts and version 18; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- Fiasp
- Generic product name
- insulin aspart injection; insulin aspart
- Active ingredient
- INSULIN ASPART
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- SPL author / labeler
- Novo Nordisk
- SPL version
- 18
- Published on DailyMed
- 2023-07-25
- SPL effective date
- 2023-06-21
- SPL set ID
- 834e7efc-393f-4c55-9125-628562a8a5cf
Product identity
Product name: Fiasp
Generic name: insulin aspart injection; insulin aspart
Active ingredients: INSULIN ASPART
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Label version
DailyMed published this record on 2023-07-25. SPL version: 18. Set ID: 834e7efc-393f-4c55-9125-628562a8a5cf. The SPL effective date is 2023-06-21.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2023-07-25. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.